Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

Prophylactic Effects of Recombinant Thrombomodulin Against Sclerodermatous Chronic Graft-Versus-Host Disease in a Rodent Model

Toshihiro Fujiki, MD, Rie Kuroda, MD, Hideaki Maeba, MD, Kazuhiro Noguchi, MD, Masaki Fukuda, MD, Shintaro Mase, MD, Raita Araki, MD, Yasuhiro Ikawa, MD PhD, Akihiro Yachie, MD PhD, Masayuki Nagasawa, MD PhD, Ryosei Nishimura, MD PhD

Blood (2017) 130 (Supplement 1): 1895.

https://doi.org/10.1182/blood.V130.Suppl_1.1895.1895

Published: 2017

Journal Articles

Third Party Cytokine-Induced Killer Cells Eliminate Highly Activated T-Cells, Leading to Protect from Murine Lethal Graft-Versus-Host Disease

Rie Kuroda, MD, Shintaro Mase, MD, Hideaki Maeba, MD, Toshihiro Fujiki, MD, Masaki Fukuda, MD, Raita Araki, MD, Yasuhiro Ikawa, MD PhD, Shoichi Koizumi, MD PhD, Akihiro Yachie, MD PhD, Ryosei Nishimura, MD PhD

Blood (2016) 128 (22): 2158.

https://doi.org/10.1182/blood.V128.22.2158.2158

Published: 2016

Journal Articles

Third Party Cytokine-Induced Killer Cells Protect from Murine Lethal Graft-Versus-Host Disease

Rie Kuroda, MD, Shintaro Mase, MD, Toshihiro Fujiki, MD, Hideaki Maeba, MD, Raita Araki, MD, Yasuhiro Ikawa, MD PhD, Masaki Fukuda, MD, Shoichi Koizumi, MD, Akihiro Yachie, MD PhD, Ryosei Nishimura, MD PhD

Blood (2015) 126 (23): 3092.

https://doi.org/10.1182/blood.V126.23.3092.3092

Published: 2015

Journal Articles

High Concentration of Immunoglobulin Allows Long-Lasting Suppression of Allo-Immune Reaction By Directly Inhibiting T-Cell Activation

Hideaki Maeba, MD, Rie Kuroda, MD, Masaki Fukuda, MD, Toshihiro Fujiki, MD, Shintaro Mase, MD, Raita Araki, MD, Yasuhiro Ikawa, MD PhD, Shoichi Koizumi, MD PhD, Akihiro Yachie, MD PhD, Ryosei Nishimura, MD PhD

Blood (2014) 124 (21): 4983.

https://doi.org/10.1182/blood.V124.21.4983.4983

Published: 2014

Journal Articles

Highly Elevated IL-18 Is a Reliable Predictor of Progression to Hemophagocytic Syndrome in the Patients with Langerhans Cell Histiocytosis

Yasuhiro Ikawa, MD PhD, Raita Araki, MD, Toshihiro Fujiki, MD, Masaki Fukuda, MD, Shintaro Mase, MD, Rie Kuroda, MD, Hideaki Maeba, MD, Shoichi Koizumi, MD PhD, Akihiro Yachie, MD PhD, Ryosei Nishimura, MD PhD

Blood (2014) 124 (21): 2736.

https://doi.org/10.1182/blood.V124.21.2736.2736

Published: 2014

Journal Articles

Thymic 18 F-FDG PET/CT Findings in Pediatric Malignant Lymphoma after Chemotherapy: Differentiation of Long-Lasting Thymic Hyperplasia from Lymphoma Recurrence

Toshihiro Fujiki, MD, Hideaki Maeba, MD, Raita Araki, MD, Yasuhiro Ikawa, MD PhD, Rie Kuroda, MD, Shintaro Mase, MD, Masaki Fukuda, MD, Shoichi Koizumi, MD PhD, Akihiro Yachie, MD PhD, Ryosei Nishimura, MD PhD

Blood (2014) 124 (21): 5409.

https://doi.org/10.1182/blood.V124.21.5409.5409

Published: 2014

Journal Articles

Simplified Monitoring of CD4 T-Cell Receptor Repertoire Provides Effective Management Strategies in the Patients with Persistent or Recurrent Graft-Versus-Host Disease

Rie Kuroda, MD, Shintaro Mase, MD, Hideaki Maeba, MD, Raita Araki, MD, Yasuhiro Ikawa, MD PhD, Toshihiro Fujiki, MD, Masaki Fukuda, MD, Shoichi Koizumi, MD PhD, Akihiro Yachie, MD PhD, Ryosei Nishimura, MD PhD

Blood (2014) 124 (21): 1162.

https://doi.org/10.1182/blood.V124.21.1162.1162

Published: 2014

Journal Articles

Both Host-Type and Donor-Type Mast Cells Protect Against Acute Graft-Versus-Host Disease

Raita Araki, MD, Hideaki Maeba, MD, Rie Kuroda, MD, Shintaro Mase, MD, Toshihiro Fujiki, MD, Yasuhiro Ikawa, MD, PhD, Shoichi Koizumi, MD, PhD, Akihiro Yachie, MD, PhD, Ryosei Nishimura, MD, PhD

Blood (2013) 122 (21): 3248.

https://doi.org/10.1182/blood.V122.21.3248.3248

Published: 2013

Journal Articles

Accurate Detection Of Renal Involvement In Pediatric Patients With Acute Lymphoblastic Leukemia By Utilizing 3D-Reconstruction Models Of Enhanced CT and Its Clinical Implications

Toshihiro Fujiki, MD, Raita Araki, MD, Shintaro Mase, MD, Rie Kuroda, MD, Yasuhiro Ikawa, MD, PhD, Hideaki Maeba, MD, Akihiro Yachie, MD, PhD, Ryosei Nishimura, MD, PhD

Blood (2013) 122 (21): 4991.

https://doi.org/10.1182/blood.V122.21.4991.4991

Published: 2013

Journal Articles

Allogeneic Cytokine-Induced Killer Cells Eliminate Host Dendritic Cells Due To The Enhanced Killing Activity By IFN-Gamma, Leading To Less Graft-Versus-Host Disease

Shintaro Mase, MD, Toshihiro Fujiki, MD, Rie Kuroda, MD, Raita Araki, MD, Hideaki Maeba, MD, Shoichi Koizumi, MD, PhD, Akihiro Yachie, MD, PhD, Ryosei Nishimura, MD, PhD

Blood (2013) 122 (21): 4495.

https://doi.org/10.1182/blood.V122.21.4495.4495

Published: 2013

Journal Articles

Natural Course Of Serum Ferritin In Childhood Cancer Survivors: Need For Iron Removal Therapy?

Hideaki Maeba, MD, Rie Kuroda, MD, Toshihiro Fujiki, MD, Shintaro Mase, MD, Raita Araki, MD, Yasuhiro Ikawa, MD, PhD, Akihiro Yachie, MD, PhD, Ryosei Nishimura, MD, PhD

Blood (2013) 122 (21): 2394.

https://doi.org/10.1182/blood.V122.21.2394.2394

Published: 2013

Journal Articles

Allogeneic Cytokine-Induced Killer Cell-Dependent Eimination of Host Dendritic Cells Leads to Less Graft-Versus-Host Disease.

Shintaro Mase, MD, Hideaki Maeba, MD, Toshihiro Fujiki, MD, Rie Kuroda, MD, Raita Araki, MD, Shoichi Koizumi, MD, PhD, Akihiro Yachie, MD, PhD, Ryosei Nishimura, MD, PhD

Blood (2012) 120 (21): 3011.

https://doi.org/10.1182/blood.V120.21.3011.3011

Published: 2012

Journal Articles

Regulatory Role of Host IL-17 Via Control of Host Macrophage Activation Contributes to Less Acute Gvhd

Rie Kuroda, MD, Katsuaki Sato, MD, PhD, Hideaki Maeba, MD, Toshihiro Fujiki, MD, Shintaro Mase, MD, Raita Araki, MD, Kazuhito Naka, PhD, Makoto Naito, MD. PhD, Yoichiro Iwakura, PhD, Akihiro Yachie, MD, PhD, Shoichi Koizumi, MD, PhD, Ryosei Nishimura, MD, PhD

Blood (2012) 120 (21): 4669.

https://doi.org/10.1182/blood.V120.21.4669.4669

Published: 2012

Journal Articles

Superior Immunomodulatory Effects of Cultured Mast Cells: Potent Strategy for Treatment of Gvhd

Raita Araki, MD, Hideaki Maeba, MD, Rie Kuroda, MD, Toshihiro Fujiki, MD, Shintaro Mase, MD, Shoichi Koizumi, MD, PhD, Akihiro Yachie, MD, PhD, Ryosei Nishimura, MD, PhD

Blood (2012) 120 (21): 4684.

https://doi.org/10.1182/blood.V120.21.4684.4684

Published: 2012

Journal Articles

Attempting to Redefine Renal Involvement by Utilizing 3D Reconstruction Models of CT Imagings in Pediatric Acute Leukemia

Toshihiro Fujiki, MD, Raita Araki, MD, Shintaro Mase, MD, Rie Kuroda, MD, Hideaki Maeba, MD, Akihiro Yachie, MD, PhD, Ryosei Nishimura, MD, PhD

Blood (2012) 120 (21): 4302.

https://doi.org/10.1182/blood.V120.21.4302.4302

Published: 2012

Journal Articles

Evaluating Prolonged Gvhd Based On Monocyte and T-Cell Activation, Leads to Early Detection of Immunological Changes Before Gvhd Exacerbations

Rie Kuroda, MD, Toshihiro Fujiki, MD, Shintaro Mase, MD, Raita Araki, MD, Hideaki Maeba, MD, Shoichi Koizumi, MD, PhD, Akihiro Yachie, MD, PhD, Ryosei Nishimura, MD, PhD

Blood (2012) 120 (21): 4178.

https://doi.org/10.1182/blood.V120.21.4178.4178

Published: 2012

Journal Articles

Only High Concentration of Immunoglobulin Inhibits Activation of Lymphocytes: Potential Use of Immunoglobulin for Preventing Gvhd

Hideaki Maeba, MD, Rie Kuroda, MD, Toshihiro Hujiki, MD, Shintaro Mase, MD, Raita Araki, MD, Shoichi Koizumi, MD, PhD, Akihiro Yachie, MD, PhD, Ryosei Nishimura, MD, PhD

Blood (2012) 120 (21): 4376.

https://doi.org/10.1182/blood.V120.21.4376.4376

Published: 2012

Journal Articles

Only Dendritic Cells, but Not Lymphocytes, Acquired Tolerogenicity by PUVA-Treatment by Upregulation of Indoleamine 2,3-Dioxygenase (IDO)

Hideaki Maeba, MD, Rie Kuroda, MD, Yo Niida, MD, PhD, Shintaro Mase, MD, Raita Araki, MD, Toshihiro Fujiki, MD, Akihiro Yachie, MD, PhD, Shoichi Koizumi, MD, PhD, Ryosei Nishimura, MD, PhD

Blood (2011) 118 (21): 2176.

https://doi.org/10.1182/blood.V118.21.2176.2176

Published: 2011

Journal Articles

Allogeneic Cytokine-Induced Killer Cells Kill Dendritic Cells Efficiently Resulting in Less Graft-Versus-Host Disease

Shintaro Mase, MD, Hideaki Maeba, MD, Rie Kuroda, MD, Raita Araki, MD, Toshihiro Fujiki, MD, Hideo Yagita, PhD, Akihiro Yachie, MD, PhD, Shoichi Koizumi, MD, PhD, Ryosei Nishimura, MD, PhD

Blood (2011) 118 (21): 4308.

https://doi.org/10.1182/blood.V118.21.4308.4308

Published: 2011

Journal Articles

Attempting to Classify Prolonged Graft-Versus-Host-Disease According to Monocyte Activation Status in Addition to T-Cell

Rie Kuroda, MD, Hideaki Maeba, MD, Shintaro Mase, MD, Raita Araki, MD, Toshihiro Fujiki, MD, Shoichi Koizumi, MD, PhD, Akihiro Yachie, MD, PhD, Ryosei Nishimura, MD, PhD

Blood (2011) 118 (21): 3045.

https://doi.org/10.1182/blood.V118.21.3045.3045

Published: 2011

NARROW

Prophylactic Effects of Recombinant Thrombomodulin Against Sclerodermatous Chronic Graft-Versus-Host Disease in a Rodent Model

Third Party Cytokine-Induced Killer Cells Eliminate Highly Activated T-Cells, Leading to Protect from Murine Lethal Graft-Versus-Host Disease

Third Party Cytokine-Induced Killer Cells Protect from Murine Lethal Graft-Versus-Host Disease

High Concentration of Immunoglobulin Allows Long-Lasting Suppression of Allo-Immune Reaction By Directly Inhibiting T-Cell Activation

Highly Elevated IL-18 Is a Reliable Predictor of Progression to Hemophagocytic Syndrome in the Patients with Langerhans Cell Histiocytosis

Thymic 18 F-FDG PET/CT Findings in Pediatric Malignant Lymphoma after Chemotherapy: Differentiation of Long-Lasting Thymic Hyperplasia from Lymphoma Recurrence

Simplified Monitoring of CD4 T-Cell Receptor Repertoire Provides Effective Management Strategies in the Patients with Persistent or Recurrent Graft-Versus-Host Disease

Both Host-Type and Donor-Type Mast Cells Protect Against Acute Graft-Versus-Host Disease

Accurate Detection Of Renal Involvement In Pediatric Patients With Acute Lymphoblastic Leukemia By Utilizing 3D-Reconstruction Models Of Enhanced CT and Its Clinical Implications

Allogeneic Cytokine-Induced Killer Cells Eliminate Host Dendritic Cells Due To The Enhanced Killing Activity By IFN-Gamma, Leading To Less Graft-Versus-Host Disease

Natural Course Of Serum Ferritin In Childhood Cancer Survivors: Need For Iron Removal Therapy?

Allogeneic Cytokine-Induced Killer Cell-Dependent Eimination of Host Dendritic Cells Leads to Less Graft-Versus-Host Disease.

Regulatory Role of Host IL-17 Via Control of Host Macrophage Activation Contributes to Less Acute Gvhd

Superior Immunomodulatory Effects of Cultured Mast Cells: Potent Strategy for Treatment of Gvhd

Attempting to Redefine Renal Involvement by Utilizing 3D Reconstruction Models of CT Imagings in Pediatric Acute Leukemia

Evaluating Prolonged Gvhd Based On Monocyte and T-Cell Activation, Leads to Early Detection of Immunological Changes Before Gvhd Exacerbations

Only High Concentration of Immunoglobulin Inhibits Activation of Lymphocytes: Potential Use of Immunoglobulin for Preventing Gvhd

Only Dendritic Cells, but Not Lymphocytes, Acquired Tolerogenicity by PUVA-Treatment by Upregulation of Indoleamine 2,3-Dioxygenase (IDO)

Allogeneic Cytokine-Induced Killer Cells Kill Dendritic Cells Efficiently Resulting in Less Graft-Versus-Host Disease

Attempting to Classify Prolonged Graft-Versus-Host-Disease According to Monocyte Activation Status in Addition to T-Cell

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only